Microsoft PowerPoint - ASCO_2010_PX[removed]discussant slides_060110v3 - Morpholines - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2012-04-18 11:53:08 Immunosuppressants Carfilzomib Epoxides Morpholines Lenalidomide Bortezomib Multiple myeloma Dexamethasone Proteasome inhibitor Chemistry Medicine Organic chemistry		Microsoft PowerPoint - ASCO_2010_PX[removed]discussant slides_060110v3 Add to Reading List Source URL: myeloma.org Download Document from Source Website File Size: 185,28 KB Share Document on Facebook

	CRAB CTC: Phase I Study of Carfilzomib (C) and Irinotecan (I) in Relapsed Irinotecan-Sensitive Solid Tumors Susanne M. Arnold, MD1; Kari Chansky, PhD2; Markos Leggas, PhD1; Michael Thomson, MD3; John Hamm, MD4; Ra DocID: 1rySF - View Document
	Take this medication early in the population studied bortezomib cadila outweighed any benefit from this medication. Oral forms of diazepam is in reality a signal that we have now is making you feel that you are in need o DocID: 1r7cr - View Document
	12-AUG:10 MMYEL ACCRUAL REPORT - Open and Recently Closed Studies SWOG/ Support STUDY DocID: 1qMvA - View Document
	Publications de l’IFM Intergroupe Francophone du MyélomeLeleu X, Attal M, Arnulf B, Moreau P, Traulle C, Marit G, Mathiot C, Petillon MO, Macro M, Roussel M, Pegourie B, Kolb B, Stoppa AM, Hennache B, Bréchi DocID: 1pTVs - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KYPROLIS safely and effectively. See full prescribing information for KYPROLIS. KYPROLIS® (carfilzomib) for Injecti DocID: 1gtjn - View Document